Analgesic Effect Between TAP Block and Continuous Wound Infusion in Abdominoplasty Surgery

Last updated: April 26, 2021
Sponsor: University of Liege
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT01862354
2013-00017214-14 2013/9
2013-000172-14
  • Ages 18-70
  • Female

Study Summary

The purpose of this randomized controlled study is to compare the postoperative analgesic effect of a continuous wound infusion of local anesthetics and a sole transverse abdominal plan (TAP) regional block in the surgery of Abdominoplasty Combined With Flank Liposuction. Local anesthetics products used are ropivacaine combined with clonidine. Similar amount of local anesthetics and clonidine are used.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients scheduled for abdominoplasty combined with flank liposuction

Exclusion

Exclusion Criteria:

  • Allergy to local anesthetics or clonidine
  • Coagulation disorders
  • History of chronic pain
  • Alcohol or drugs dependance
  • Refusal of the patients

Study Design

Total Participants: 50
Study Start date:
June 01, 2013
Estimated Completion Date:
December 31, 2021

Study Description

In a first group, patients receive, after induction of anaesthesia and before surgery, a TAP block (transverse abdominal plan block) with 3mg/kg Ropivacaine 0.5% (maximum 200 mg) and 150 microg Clonidine.

In a second group, before skin closure, a multiholes catheter was inserted beyond the skin. 20 mg Ropivacaine 0.2% added with 150 microg Clonidine was injected as bolus dose through this catheter followed by a continuous infusion of Ropivacaine 0.2% 10ml per hour during the following 9 hours (total dose of 200 mgr).

Connect with a study center

  • University of Liege, University Hospital

    Liege, 4000
    Belgium

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.